Cargando…

Leptin: A Novel Therapeutic Target in Alzheimer's Disease?

It is well established that the hormone leptin circulates in the plasma in amounts proportional to body fat content and it regulates food intake and body weight via its actions in the hypothalamus. However, numerous studies have shown that leptin receptors are widely expressed throughout the CNS and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beccano-Kelly, Dayne, Harvey, Jenni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255100/ https://www.ncbi.nlm.nih.gov/pubmed/22254146 http://dx.doi.org/10.1155/2012/594137

Ejemplares similares

The Neuronal Actions of Leptin and the Implications for Treating Alzheimer’s Disease
por: Hamilton, Kirsty, et al.
Publicado: (2021)

Impaired dopamine release in Parkinson’s disease
por: Cramb, Kaitlyn M L, et al.
Publicado: (2023)

Exosomes: a novel therapeutic target for Alzheimer’s disease?
por: Cai, Zhi-You, et al.
Publicado: (2018)

Hyperexcitability in young iPSC-derived C9ORF72 mutant motor neurons is associated with increased intracellular calcium release
por: Burley, Sarah, et al.
Publicado: (2022)

Leptin in depression: a potential therapeutic target
por: Ge, Tongtong, et al.
Publicado: (2018)

Leptin regulation of neuronal excitability and cognitive function
por: Harvey, Jenni
Publicado: (2007)

Food for Thought: Leptin and Hippocampal Synaptic Function
por: Harvey, Jenni
Publicado: (2022)

Leptin regulation of neuronal morphology and hippocampal synaptic function
por: Harvey, Jenni
Publicado: (2013)

Propagation of tau pathology in Alzheimer’s disease: identification of novel therapeutic targets
por: Pooler, Amy M, et al.
Publicado: (2013)

From Synaptic Dysfunction to Neuroprotective Strategies in Genetic Parkinson’s Disease: Lessons From LRRK2
por: Mancini, Andrea, et al.
Publicado: (2020)

Incretin and insulin signaling as novel therapeutic targets for Alzheimer’s and Parkinson’s disease
por: Nowell, Joseph, et al.
Publicado: (2022)

Obesity as a Risk Factor for Dementia and Alzheimer’s Disease: The Role of Leptin
por: Flores-Cordero, Juan Antonio, et al.
Publicado: (2022)

Regulation of Hippocampal Synaptic Function by the Metabolic Hormone, Leptin: Implications for Health and Neurodegenerative Disease
por: McGregor, Gemma, et al.
Publicado: (2018)

Hypometabolism as a therapeutic target in Alzheimer's disease
por: Costantini, Lauren C, et al.
Publicado: (2008)

Creatine as a Therapeutic Target in Alzheimer's Disease
por: Smith, Aaron N., et al.
Publicado: (2023)

Brain Renin–Angiotensin System as Novel and Potential Therapeutic Target for Alzheimer’s Disease
por: Loera-Valencia, Raúl, et al.
Publicado: (2021)

Rho GTPases as therapeutic targets in Alzheimer’s disease
por: Aguilar, Byron J., et al.
Publicado: (2017)

Alterations in brain leptin signalling in spite of unchanged CSF leptin levels in Alzheimer’s disease
por: Maioli, Silvia, et al.
Publicado: (2015)

Understanding PDE4's function in Alzheimer's disease; a target for novel therapeutic approaches
por: Tibbo, Amy J., et al.
Publicado: (2019)

Activating Leptin Receptors in the Central Nervous System Using Intranasal Leptin. A Novel Therapeutic Target for Sleep-disordered Breathing
por: Ip, Mary S. M., et al.
Publicado: (2019)

NADPH oxidase as a therapeutic target in Alzheimer's disease
por: Block, Michelle L
Publicado: (2008)

Neuroinflammation as a Potential Therapeutic Target in Alzheimer’s Disease
por: Liu, Ping, et al.
Publicado: (2022)

The Immune System as a Therapeutic Target for Alzheimer’s Disease
por: Zieneldien, Tarek, et al.
Publicado: (2022)

Palmitoylation of δ-catenin by DHHC5 Mediates Activity-Induced Synapse Plasticity
por: Brigidi, G. Stefano, et al.
Publicado: (2014)

Altered Brain Leptin and Leptin Receptor Expression in the 5XFAD Mouse Model of Alzheimer’s Disease
por: Pratap, Anishchal A., et al.
Publicado: (2020)

Diverse Molecular Targets for Therapeutic Strategies in Alzheimer's Disease
por: Han, Sun-Ho, et al.
Publicado: (2014)

Therapeutic Strategies to Target Calcium Dysregulation in Alzheimer’s Disease
por: Calvo-Rodriguez, Maria, et al.
Publicado: (2020)

Therapeutic Targeting of Rab GTPases: Relevance for Alzheimer’s Disease
por: Jordan, Kate L., et al.
Publicado: (2022)

Therapeutic Potential of Targeting Mitochondria for Alzheimer’s Disease Treatment
por: Atlante, Anna, et al.
Publicado: (2022)

Hypometabolism, Alzheimer’s Disease, and Possible Therapeutic Targets: An Overview
por: Raut, Snehal, et al.
Publicado: (2023)

Novel therapeutic target against Alzheimer
por: LeBlanc, Andrea C.
Publicado: (2017)

Leptin Regulation of Synaptic Function at Hippocampal TA-CA1 and SC-CA1 Synapses: Implications for Health and Disease
por: McGregor, Gemma, et al.
Publicado: (2017)

Advances in developing novel therapeutic strategies for Alzheimer’s disease
por: Cao, Jiqing, et al.
Publicado: (2018)

Novel Therapeutic Approaches for Alzheimer’s Disease: An Updated Review
por: Yu, Tien-Wei, et al.
Publicado: (2021)

ApoE Lipidation as a Therapeutic Target in Alzheimer’s Disease
por: Lanfranco, Maria Fe, et al.
Publicado: (2020)

Mitochondrial complex I as a therapeutic target for Alzheimer's disease
por: Trushina, Eugenia, et al.
Publicado: (2022)

Noradrenaline in Alzheimer’s Disease: A New Potential Therapeutic Target
por: Gutiérrez, Irene L., et al.
Publicado: (2022)

Molecular Targets in Alzheimer's Disease: From Pathogenesis to Therapeutics
por: Cheng, Xuan, et al.
Publicado: (2015)

Mini review: Prospective therapeutic targets of Alzheimer's disease
por: Mangal, Ruchi, et al.
Publicado: (2022)

Targeting Endothelin in Alzheimer's Disease: A Promising Therapeutic Approach
por: Sharma, Shiwali, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_moljlo5tt48kg4oljg4cnb7e22